Article(id=1322246467029414531, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322246421869346895, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1607270400000, acceptedDateStr=2020-12-07, onlineDate=1793177723891, onlineDateStr=2026-10-28, pubDate=1624982400000, pubDateStr=2021-06-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793177723891, onlineIssueDateStr=2026-10-28, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793177723891, creator=13701087609, updateTime=1793177723891, updator=13701087609, issue=Issue{id=1322246421869346895, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='12', pageStart='1057', pageEnd='1152', issueExtLink='null', onlineDate='null', pubDate='1624982400000', pubDateStr='2021-06-30', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793177713123, creator='13701087609', updateTime=1793178158604, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322248290402414824, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322246421869346895, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322248290402414825, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322246421869346895, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1132, endPage=1136, ext={EN=ArticleExt(id=1322246467197186692, articleId=1322246467029414531, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=An initiative to establish coordinated and consistent causality assessment criteria for adverse drug reaction in clinical trials, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

Establishment of causality between drug exposure and adverse event, namely adverse drug reaction (ADR) assessment, is a crucial procedure in drug safety evaluation. While various causality assessment tools for ADR have been published, the poor agreement among them hinders the collection, analysis and interchange of drug safety data, and causes confusion for ADR research as well. The correlation of safety information throughout the whole process of clinical trials is important, so it is well-advised to maintain causality assessment criteria as coherent and consistent in both pre-marketing and post-marketing stages. Furthermore, the application of the WHO-UMC and ICH causality assessment system may promote ADR causality assessment standardization. Since joining the ICH, China has developed a series of regulations and guidelines on ADR monitoring and evaluation. However, these documents remain unclear towards the operating instructions for ADR assessment, especially in the early pre-marketing stages. Accordingly, we suggest that coordinated and consistent causality assessment criteria and relevant operating instructions be developed to improve the data sharing and continuity of drug safety monitoring in China.

, authors=Qian HUANG1, Ze-huai WEN2, 3, authorsList=Qian HUANG, Ze-huai WEN, authorCompany=null, correspAuthors=Ze-huai WEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322246467440456325, articleId=1322246467029414531, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=倡议建立协调统一的药物不良反应因果关系评价标准, columnId=1236331163573342670, journalTitle=中国新药杂志, columnName=药物安全与合理应用, runingTitle=null, highlight=null, articleAbstract=

评价个体的不良事件(adverse event,AE)与药物的因果关系,即药物不良反应(adverse drug reaction,ADR)因果关系判断是药物安全性评价的关键。在上市前及上市后的不同研究阶段,ADR判断、监测和评价虽各有侧重,但保持ADR因果关系评价标准在整个研发过程中的连贯性、协调性甚为重要。现行的个体ADR因果关系评价方法多样,不同方法判断结论的差异阻碍了药物安全性数据的汇总、分析和交流,也对ADR研究造成困扰。推广及应用WHO乌普萨拉监测中心(WHO-UMC)和国际人用药品注册技术协调会(ICH)的ADR因果关系评价标准和方法,将有力促进ADR因果关系判断的标准化。我国自加入ICH后,逐步建立起与国际接轨的试验及数据传输标准,但有关ADR监测与评价的法规对于ADR因果关系判断的操作说明仍较模糊,尚无文件明确说明上市前ADR因果关系评价的操作细节。因此,我们倡议制订覆盖药品研发全周期、统一协调、包含操作说明的ADR因果关系判定标准,以进一步改善我国药物安全性监测的连续性和数据共享。

, authors=黄仟1, 温泽淮2, 3, authorsList=黄仟, 温泽淮, authorCompany=null, correspAuthors=温泽淮, authorNote=

黄仟,女,博士研究生,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。

, correspAuthorsNote=
温泽淮,男,研究员,博士生导师,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=xRpywqAvFpyknehzXHqJxA==, magXml=CeVZY7B1kTnSIM94CmbPRw==, pdfUrl=null, pdf=+IY16x8CQhDav7hwXEdboA==, pdfFileSize=944387, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=KYyfst6tR2VH2Zj/SOfgoQ==, mapNumber=null, fund=null)}, authors=[Author(id=1322246467939578512, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=huangqian_2018@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322246468027658898, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, authorId=1322246467939578512, language=EN, stringName=Qian HUANG, firstName=Qian, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322246468094767763, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, authorId=1322246467939578512, language=CN, stringName=黄仟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1广州中医药大学第二临床医学院,广州 510120, bio={"content":"

黄仟,女,博士研究生,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。

"}, bioImg=null, bioContent=

黄仟,女,博士研究生,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322246467641782918, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=1, ext=[AuthorCompanyExt(id=1322246467650171527, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467641782918, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, China), AuthorCompanyExt(id=1322246467662754440, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467641782918, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1广州中医药大学第二临床医学院,广州 510120)])]), Author(id=1322246468174459541, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wenzh@gzucm.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322246468270928536, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, authorId=1322246468174459541, language=EN, stringName=Ze-huai WEN, firstName=Ze-huai, middleName=null, lastName=WEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2Key Unit of Methodology in Clinical Research Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
3National Center for Design, Measurement and Evaluation in Clinical Research, Guangzhou University of Chinese Medicine, Guangzhou 510405, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322246468350620313, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, authorId=1322246468174459541, language=CN, stringName=温泽淮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2广东省中医院临床研究方法学重点研究室,广州 510120
3广州中医药大学DME中心,广州 510405, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322246467746640521, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=2, ext=[AuthorCompanyExt(id=1322246467759223434, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467746640521, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Key Unit of Methodology in Clinical Research Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China), AuthorCompanyExt(id=1322246467767612043, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467746640521, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2广东省中医院临床研究方法学重点研究室,广州 510120)]), AuthorCompany(id=1322246467834720908, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=3, ext=[AuthorCompanyExt(id=1322246467851498125, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467834720908, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3National Center for Design, Measurement and Evaluation in Clinical Research, Guangzhou University of Chinese Medicine, Guangzhou 510405, China), AuthorCompanyExt(id=1322246467859886734, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467834720908, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3广州中医药大学DME中心,广州 510405)])])], keywords=[Keyword(id=1322246468463866522, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=EN, orderNo=1, keyword=adverse drug reaction), Keyword(id=1322246468547752603, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=EN, orderNo=2, keyword=adverse event), Keyword(id=1322246468631638684, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=EN, orderNo=3, keyword=causality assessment), Keyword(id=1322246468707136157, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=EN, orderNo=4, keyword=relevance judgments), Keyword(id=1322246468778439326, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=EN, orderNo=5, keyword=clinical trials), Keyword(id=1322246468858131103, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=CN, orderNo=1, keyword=不良反应), Keyword(id=1322246468933628576, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=CN, orderNo=2, keyword=不良事件), Keyword(id=1322246469004931745, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=CN, orderNo=3, keyword=因果关系判断), Keyword(id=1322246469084623522, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=CN, orderNo=4, keyword=关联性评价), Keyword(id=1322246469151732387, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, language=CN, orderNo=5, keyword=临床试验)], refs=[Reference(id=1322246469340476069, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. Clinical Safety Data Safety Data Management: Definitions and Standards for Expedited Reporting A (E2A)[EB/OL]. (1995-05-01) [2020-05-08]. https://database.ich.org/sites/default/files/E2A_Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1322246471009809062, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. Guideline For Good Clinical Practice E6 (R2)[EB/OL]. (2016-11-09) [2020-05-03]. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf., articleTitle=null, refAbstract=null), Reference(id=1322246471093695143, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局, 国家卫生健康委. 关于发布药物临床试验质量管理规范的公告(2020年第57号)[EB/OL]. [2020-05-18]. http://www.nmpa.gov.cn/WS04/CL2138/376852.html., articleTitle=null, refAbstract=null), Reference(id=1322246471198552744, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting (E2D)[EB/OL]. (2003-11-12) [2020-05-03]. https://database.ich.org/sites/default/files/E2D_Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1322246471299216041, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=中华人民共和国卫生部. 《药品不良反应报告和监测管理办法》(卫生部令第81号)[EB/OL]. (2011-05-30) [2020-05-08]. http://www.nmpa.gov.cn/WS04/CL2174/300642.html., articleTitle=null, refAbstract=null), Reference(id=1322246471378907818, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品不良反应监测中心. 药品不良反应报告和监测工作手册[EB/OL]. (2012). https://wenku.baidu.com/view/b7957683caaedd3383c4d3f0.html., articleTitle=null, refAbstract=null), Reference(id=1322246471479571115, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=杨悦. 我国药物警戒制度实施与ICH药物警戒指导原则转化适用[J]. 中国药物警戒, 2020, 17(2): 65-71., articleTitle=null, refAbstract=null), Reference(id=1322246471567651500, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=杨焕. 新药上市前临床试验安全性数据的分析与评价[J]. 中国临床药理学杂志, 2009, 25(5): 464-466., articleTitle=null, refAbstract=null), Reference(id=1322246471643148973, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=张晓雨, 王燕平, 林丽开, 等. 中药注射剂上市后整体评价的思路与关键[J]. 中国中药杂志, 2017, 42(16): 3229-3232., articleTitle=null, refAbstract=null), Reference(id=1322246471735423662, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=魏戌, 谢雁鸣. 国内外不良反应因果判断原则及评价方法解读[J]. 中国中药杂志, 2012, 37(18): 2744-2747., articleTitle=null, refAbstract=null), Reference(id=1322246471852864175, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=刘晶, 谢雁鸣, 盖国忠, 等. 药品不良反应术语集WHOART与MedDRA的应用探析[J]. 中国中药杂志, 2015, 40(24): 4728-4733., articleTitle=null, refAbstract=null), Reference(id=1322246471932555952, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=曾繁典, 郑永远, 詹思延, 等. 药物流行病学[M]. 第2版. 北京: 中国医药科技出版社, 2016., articleTitle=null, refAbstract=null), Reference(id=1322246471991276209, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=魏晶, 王瑜歆. 药品不良反应报告因果关系评价方法概述[J]. 中国药物警戒, 2011, 8(10): 600-603., articleTitle=null, refAbstract=null), Reference(id=1322246472070967986, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=李博, 高蕊, 李睿, 等. 药物临床试验不良反应/不良事件关联性判定方法研究探讨[J]. 中国新药杂志, 2014, 23(12): 1465-1470., articleTitle=null, refAbstract=null), Reference(id=1322246472146465459, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=冯硕, 刘文佳, 胡晶, 等. 药品安全性评价技术及其在中药领域的应用[J]. 中国合理用药探索, 2020, 17(1): 28-31., articleTitle=null, refAbstract=null), Reference(id=1322246472326820533, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=詹思延. 药物流行病学研究方法与药品风险管理[J]. 药物流行病学杂志, 2013, 22(4): 199-204., articleTitle=null, refAbstract=null), Reference(id=1322246472402318006, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=刘建平, 邢建民. 循证的药品不良反应评价方法[J]. 中国药物警戒, 2010, 7(1): 12-15., articleTitle=null, refAbstract=null), Reference(id=1322246472473621175, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=吴嘉瑞, 张冰, 董玲, 等. 药物流行病学在药品不良反应监测与评价中的应用[J]. 中国医药指南, 2012, 10(21): 57-58., articleTitle=null, refAbstract=null), Reference(id=1322246472758833848, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO-UMC. The use of the WHO-UMC system for standardised case causality assessment[EB/OL]. (2012-04-17) [2020-05-28]. https://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf., articleTitle=null, refAbstract=null), Reference(id=1322246472838525625, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs) E2B (R3) Data Elements and Message Specification[EB/OL]. (2016-11-10) [2020-05-28]. http://www.cde.org.cn/ichWeb/guideIch/toGuideIch/3/0., articleTitle=null, refAbstract=null), Reference(id=1322246472914023098, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=杨华, 魏晶, 王嘉仡, 等. 药品不良反应/事件报告评价方法研究[J]. 中国药物警戒, 2009, 6(10): 581-584., articleTitle=null, refAbstract=null), Reference(id=1322246473010492091, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=李涛, 鲁喦. 新药Ⅰ期临床试验中不良事件关联性评价存在的问题与对策[J]. 中国新药杂志, 2011, 20(2): 101-105., articleTitle=null, refAbstract=null), Reference(id=1322246473081795260, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH. Structure and Content of Clinical Study Reports (E3)[EB/OL]. (1995-11-30) [2020-5-30]. https://database.ich.org/sites/default/files/E3_Guideline.pdf., articleTitle=null, refAbstract=null), Reference(id=1322246473144709821, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=杜文民, 王永铭, 程能能. 药品不良反应的判定与其研究方法(续完)[J]. 中国药物警戒, 2005, 2(1): 11-13., articleTitle=null, refAbstract=null), Reference(id=1322246473216012990, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=董铎, 刘巍, 杨乐, 等. 欧盟药品不良反应管理和上报指南简介[J]. 中国药物警戒, 2014, 11(10): 611-613, 617., articleTitle=null, refAbstract=null), Reference(id=1322246473278927551, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=陈诗琪, 郑蕊, 李幼平, 等. 不良反应因果关系判定方法对上市后中成药安全性评价的指导意义[J]. 世界科学技术-中医药现代化, 2018, 20(10): 1729-1733., articleTitle=null, refAbstract=null), Reference(id=1322246473346036416, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局. 中药药源性肝损伤临床评价技术指导原则[EB/OL]. (2018-06-19) [2020-05-18]. http://www.cde.org.cn/zdyz.do?method=largePage&id=a707338103c73e83., articleTitle=null, refAbstract=null), Reference(id=1322246473417339585, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=葛斐林, 郭玉明, 曹俊岭, 等. 中药药源性肝损伤评价方法及风险因素研究进展[J]. 中国现代中药, 2019, 21(3): 284-290., articleTitle=null, refAbstract=null), Reference(id=1322246473501225666, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=徐波, 王彦. 药物临床试验期间药物安全监控体系的中外比较分析[J]. 中国新药杂志, 2009, 18(14): 1291-1293., articleTitle=null, refAbstract=null), Reference(id=1322246473576723139, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=王春华, 胡晓, 杨翠翠, 等. Ⅰ期临床试验中不良事件的因果关系评价[J]. 药物不良反应杂志, 2019, 21(1): 30-35., articleTitle=null, refAbstract=null), Reference(id=1322246473685775044, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=曹烨, 万邦喜, 苏敏实. 药物临床试验 安全评价·广东共识(2020年版)[J]. 今日药学, 2020, 30(11): 731-740., articleTitle=null, refAbstract=null), Reference(id=1322246473765466821, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局. 关于发布个例药品不良反应收集和报告指导原则的通告(2018年第131号)[EB/OL]. (2018-12-19) [2020-05-16]. http://www.nmpa.gov.cn/WS04/CL2138/334011.html., articleTitle=null, refAbstract=null), Reference(id=1322246473966793414, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=刘欢, 张钟艺, 杨悦. 新药临床试验中安全性报告管理[J]. 中国药物警戒, 2019, 16(2): 88-93., articleTitle=null, refAbstract=null), Reference(id=1322246475619349191, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=赵世丹, 鲁仲平. 影响个例药品不良反应报告评价的因素[J]. 中国药物警戒, 2012, 9(9): 553-555., articleTitle=null, refAbstract=null), Reference(id=1322246475732595400, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=牛瑞, 冯变玲, 林蓉. 国际药品不良反应报告的研究进展[J]. 中国合理用药探索, 2020, 17(1): 24-27., articleTitle=null, refAbstract=null), Reference(id=1322246475803898569, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=郭韶洁, 赵秀丽, 周辉. 临床试验中不良事件管理的问题及分析[J]. 中国临床药理学杂志, 2014, 30(1): 73-74, 77., articleTitle=null, refAbstract=null)], funds=[Fund(id=1322246469248201380, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, awardId=2018YFC1707407, language=CN, fundingSource=国家重点研发计划课题资助项目(2018YFC1707407), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1322246467641782918, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=1, ext=[AuthorCompanyExt(id=1322246467650171527, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467641782918, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, China), AuthorCompanyExt(id=1322246467662754440, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467641782918, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1广州中医药大学第二临床医学院,广州 510120)]), AuthorCompany(id=1322246467746640521, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=2, ext=[AuthorCompanyExt(id=1322246467759223434, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467746640521, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Key Unit of Methodology in Clinical Research Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China), AuthorCompanyExt(id=1322246467767612043, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467746640521, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2广东省中医院临床研究方法学重点研究室,广州 510120)]), AuthorCompany(id=1322246467834720908, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=3, ext=[AuthorCompanyExt(id=1322246467851498125, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467834720908, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3National Center for Design, Measurement and Evaluation in Clinical Research, Guangzhou University of Chinese Medicine, Guangzhou 510405, China), AuthorCompanyExt(id=1322246467859886734, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467834720908, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3广州中医药大学DME中心,广州 510405)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I12/1132, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I12/1132, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I12/1132, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I12/1132, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1624982400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
倡议建立协调统一的药物不良反应因果关系评价标准
收藏切换
PDF下载
黄仟 1 , 温泽淮 2, 3
中国新药杂志 | 药物安全与合理应用 2021,30(12): 1132-1136
收起
收藏切换
中国新药杂志 |药物安全与合理应用 2021 , 30 (12) : 1132 -1136
倡议建立协调统一的药物不良反应因果关系评价标准
全屏
[Author(id=1322246467939578512, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=huangqian_2018@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322246468027658898, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, authorId=1322246467939578512, language=EN, stringName=Qian HUANG, firstName=Qian, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322246468094767763, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, authorId=1322246467939578512, language=CN, stringName=黄仟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1广州中医药大学第二临床医学院,广州 510120, bio={"content":"

黄仟,女,博士研究生,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。

"}, bioImg=null, bioContent=

黄仟,女,博士研究生,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322246467641782918, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=1, ext=[AuthorCompanyExt(id=1322246467650171527, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467641782918, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, China), AuthorCompanyExt(id=1322246467662754440, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467641782918, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1广州中医药大学第二临床医学院,广州 510120)])]), Author(id=1322246468174459541, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wenzh@gzucm.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322246468270928536, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, authorId=1322246468174459541, language=EN, stringName=Ze-huai WEN, firstName=Ze-huai, middleName=null, lastName=WEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2Key Unit of Methodology in Clinical Research Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
3National Center for Design, Measurement and Evaluation in Clinical Research, Guangzhou University of Chinese Medicine, Guangzhou 510405, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322246468350620313, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, authorId=1322246468174459541, language=CN, stringName=温泽淮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, address=2广东省中医院临床研究方法学重点研究室,广州 510120
3广州中医药大学DME中心,广州 510405, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322246467746640521, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=2, ext=[AuthorCompanyExt(id=1322246467759223434, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467746640521, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2Key Unit of Methodology in Clinical Research Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China), AuthorCompanyExt(id=1322246467767612043, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467746640521, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2广东省中医院临床研究方法学重点研究室,广州 510120)]), AuthorCompany(id=1322246467834720908, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, xref=3, ext=[AuthorCompanyExt(id=1322246467851498125, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467834720908, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3National Center for Design, Measurement and Evaluation in Clinical Research, Guangzhou University of Chinese Medicine, Guangzhou 510405, China), AuthorCompanyExt(id=1322246467859886734, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322246467029414531, companyId=1322246467834720908, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3广州中医药大学DME中心,广州 510405)])])]
黄仟1 , 温泽淮2, 3
作者信息
  • 1广州中医药大学第二临床医学院,广州 510120
  • 2广东省中医院临床研究方法学重点研究室,广州 510120
  • 3广州中医药大学DME中心,广州 510405
通讯作者:
温泽淮,男,研究员,博士生导师,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。
作者简介:

黄仟,女,博士研究生,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。

An initiative to establish coordinated and consistent causality assessment criteria for adverse drug reaction in clinical trials
Qian HUANG1 , Ze-huai WEN2, 3
Affiliations
  • 1The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, China
  • 2Key Unit of Methodology in Clinical Research Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
  • 3National Center for Design, Measurement and Evaluation in Clinical Research, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
出版时间: 2021-06-30
文章导航
收藏切换

评价个体的不良事件(adverse event,AE)与药物的因果关系,即药物不良反应(adverse drug reaction,ADR)因果关系判断是药物安全性评价的关键。在上市前及上市后的不同研究阶段,ADR判断、监测和评价虽各有侧重,但保持ADR因果关系评价标准在整个研发过程中的连贯性、协调性甚为重要。现行的个体ADR因果关系评价方法多样,不同方法判断结论的差异阻碍了药物安全性数据的汇总、分析和交流,也对ADR研究造成困扰。推广及应用WHO乌普萨拉监测中心(WHO-UMC)和国际人用药品注册技术协调会(ICH)的ADR因果关系评价标准和方法,将有力促进ADR因果关系判断的标准化。我国自加入ICH后,逐步建立起与国际接轨的试验及数据传输标准,但有关ADR监测与评价的法规对于ADR因果关系判断的操作说明仍较模糊,尚无文件明确说明上市前ADR因果关系评价的操作细节。因此,我们倡议制订覆盖药品研发全周期、统一协调、包含操作说明的ADR因果关系判定标准,以进一步改善我国药物安全性监测的连续性和数据共享。

不良反应  /  不良事件  /  因果关系判断  /  关联性评价  /  临床试验

Establishment of causality between drug exposure and adverse event, namely adverse drug reaction (ADR) assessment, is a crucial procedure in drug safety evaluation. While various causality assessment tools for ADR have been published, the poor agreement among them hinders the collection, analysis and interchange of drug safety data, and causes confusion for ADR research as well. The correlation of safety information throughout the whole process of clinical trials is important, so it is well-advised to maintain causality assessment criteria as coherent and consistent in both pre-marketing and post-marketing stages. Furthermore, the application of the WHO-UMC and ICH causality assessment system may promote ADR causality assessment standardization. Since joining the ICH, China has developed a series of regulations and guidelines on ADR monitoring and evaluation. However, these documents remain unclear towards the operating instructions for ADR assessment, especially in the early pre-marketing stages. Accordingly, we suggest that coordinated and consistent causality assessment criteria and relevant operating instructions be developed to improve the data sharing and continuity of drug safety monitoring in China.

adverse drug reaction  /  adverse event  /  causality assessment  /  relevance judgments  /  clinical trials
黄仟, 温泽淮. 倡议建立协调统一的药物不良反应因果关系评价标准. 中国新药杂志, 2021 , 30 (12) : 1132 -1136 .
Qian HUANG, Ze-huai WEN. An initiative to establish coordinated and consistent causality assessment criteria for adverse drug reaction in clinical trials[J]. Chinese Journal of New Drugs, 2021 , 30 (12) : 1132 -1136 .
  • 国家重点研发计划课题资助项目(2018YFC1707407)
参考文献 引证文献
排序方式:
[1]
ICH. Clinical Safety Data Safety Data Management: Definitions and Standards for Expedited Reporting A (E2A)[EB/OL]. (1995-05-01) [2020-05-08]. https://database.ich.org/sites/default/files/E2A_Guideline.pdf.
[2]
ICH. Guideline For Good Clinical Practice E6 (R2)[EB/OL]. (2016-11-09) [2020-05-03]. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf.
[3]
国家药品监督管理局, 国家卫生健康委. 关于发布药物临床试验质量管理规范的公告(2020年第57号)[EB/OL]. [2020-05-18]. http://www.nmpa.gov.cn/WS04/CL2138/376852.html.
[4]
ICH. Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting (E2D)[EB/OL]. (2003-11-12) [2020-05-03]. https://database.ich.org/sites/default/files/E2D_Guideline.pdf.
[5]
中华人民共和国卫生部. 《药品不良反应报告和监测管理办法》(卫生部令第81号)[EB/OL]. (2011-05-30) [2020-05-08]. http://www.nmpa.gov.cn/WS04/CL2174/300642.html.
[6]
国家药品不良反应监测中心. 药品不良反应报告和监测工作手册[EB/OL]. (2012). https://wenku.baidu.com/view/b7957683caaedd3383c4d3f0.html.
[7]
杨悦. 我国药物警戒制度实施与ICH药物警戒指导原则转化适用[J]. 中国药物警戒, 2020, 17(2): 65-71.
[8]
杨焕. 新药上市前临床试验安全性数据的分析与评价[J]. 中国临床药理学杂志, 2009, 25(5): 464-466.
[9]
张晓雨, 王燕平, 林丽开, 等. 中药注射剂上市后整体评价的思路与关键[J]. 中国中药杂志, 2017, 42(16): 3229-3232.
[10]
魏戌, 谢雁鸣. 国内外不良反应因果判断原则及评价方法解读[J]. 中国中药杂志, 2012, 37(18): 2744-2747.
[11]
刘晶, 谢雁鸣, 盖国忠, 等. 药品不良反应术语集WHOART与MedDRA的应用探析[J]. 中国中药杂志, 2015, 40(24): 4728-4733.
[12]
曾繁典, 郑永远, 詹思延, 等. 药物流行病学[M]. 第2版. 北京: 中国医药科技出版社, 2016.
[13]
魏晶, 王瑜歆. 药品不良反应报告因果关系评价方法概述[J]. 中国药物警戒, 2011, 8(10): 600-603.
[14]
李博, 高蕊, 李睿, 等. 药物临床试验不良反应/不良事件关联性判定方法研究探讨[J]. 中国新药杂志, 2014, 23(12): 1465-1470.
[15]
冯硕, 刘文佳, 胡晶, 等. 药品安全性评价技术及其在中药领域的应用[J]. 中国合理用药探索, 2020, 17(1): 28-31.
[16]
詹思延. 药物流行病学研究方法与药品风险管理[J]. 药物流行病学杂志, 2013, 22(4): 199-204.
[17]
刘建平, 邢建民. 循证的药品不良反应评价方法[J]. 中国药物警戒, 2010, 7(1): 12-15.
[18]
吴嘉瑞, 张冰, 董玲, 等. 药物流行病学在药品不良反应监测与评价中的应用[J]. 中国医药指南, 2012, 10(21): 57-58.
[19]
WHO-UMC. The use of the WHO-UMC system for standardised case causality assessment[EB/OL]. (2012-04-17) [2020-05-28]. https://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf.
[20]
ICH. Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs) E2B (R3) Data Elements and Message Specification[EB/OL]. (2016-11-10) [2020-05-28]. http://www.cde.org.cn/ichWeb/guideIch/toGuideIch/3/0.
[21]
杨华, 魏晶, 王嘉仡, 等. 药品不良反应/事件报告评价方法研究[J]. 中国药物警戒, 2009, 6(10): 581-584.
[22]
李涛, 鲁喦. 新药Ⅰ期临床试验中不良事件关联性评价存在的问题与对策[J]. 中国新药杂志, 2011, 20(2): 101-105.
[23]
ICH. Structure and Content of Clinical Study Reports (E3)[EB/OL]. (1995-11-30) [2020-5-30]. https://database.ich.org/sites/default/files/E3_Guideline.pdf.
[24]
杜文民, 王永铭, 程能能. 药品不良反应的判定与其研究方法(续完)[J]. 中国药物警戒, 2005, 2(1): 11-13.
[25]
董铎, 刘巍, 杨乐, 等. 欧盟药品不良反应管理和上报指南简介[J]. 中国药物警戒, 2014, 11(10): 611-613, 617.
[26]
陈诗琪, 郑蕊, 李幼平, 等. 不良反应因果关系判定方法对上市后中成药安全性评价的指导意义[J]. 世界科学技术-中医药现代化, 2018, 20(10): 1729-1733.
[27]
国家药品监督管理局. 中药药源性肝损伤临床评价技术指导原则[EB/OL]. (2018-06-19) [2020-05-18]. http://www.cde.org.cn/zdyz.do?method=largePage&id=a707338103c73e83.
[28]
葛斐林, 郭玉明, 曹俊岭, 等. 中药药源性肝损伤评价方法及风险因素研究进展[J]. 中国现代中药, 2019, 21(3): 284-290.
[29]
徐波, 王彦. 药物临床试验期间药物安全监控体系的中外比较分析[J]. 中国新药杂志, 2009, 18(14): 1291-1293.
[30]
王春华, 胡晓, 杨翠翠, 等. Ⅰ期临床试验中不良事件的因果关系评价[J]. 药物不良反应杂志, 2019, 21(1): 30-35.
[31]
曹烨, 万邦喜, 苏敏实. 药物临床试验 安全评价·广东共识(2020年版)[J]. 今日药学, 2020, 30(11): 731-740.
[32]
国家药品监督管理局. 关于发布个例药品不良反应收集和报告指导原则的通告(2018年第131号)[EB/OL]. (2018-12-19) [2020-05-16]. http://www.nmpa.gov.cn/WS04/CL2138/334011.html.
[33]
刘欢, 张钟艺, 杨悦. 新药临床试验中安全性报告管理[J]. 中国药物警戒, 2019, 16(2): 88-93.
[34]
赵世丹, 鲁仲平. 影响个例药品不良反应报告评价的因素[J]. 中国药物警戒, 2012, 9(9): 553-555.
[35]
牛瑞, 冯变玲, 林蓉. 国际药品不良反应报告的研究进展[J]. 中国合理用药探索, 2020, 17(1): 24-27.
[36]
郭韶洁, 赵秀丽, 周辉. 临床试验中不良事件管理的问题及分析[J]. 中国临床药理学杂志, 2014, 30(1): 73-74, 77.
2021年第30卷第12期
PDF下载
13
3
引用本文
BibTeX
文章信息
  • 首发时间:2026-10-28
  • 出版时间:2021-06-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2020-12-07
基金
国家重点研发计划课题资助项目(2018YFC1707407)
作者信息
    1广州中医药大学第二临床医学院,广州 510120
    2广东省中医院临床研究方法学重点研究室,广州 510120
    3广州中医药大学DME中心,广州 510405

通讯作者:

温泽淮,男,研究员,博士生导师,研究方向:临床流行病学方法应用。联系电话:(020)81887233-35837,E-mail:。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322246467029414531
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏